Harrow HROW
NASDAQ HROW
$41.39 -0.25 (-0.60%)
At close: Aug 20, 2026 · 1:45 PM UTC

Harrow (HROW) EBT Margin (2013 - 2026)

Harrow (HROW) posted quarterly EBT Margin of 62.39% for Q1 2026, down 2521.0% year-over-year from 2.58% in Q1 2025, and down 634.6% quarter-over-quarter from 11.67% in Q4 2025.

Harrow (HROW) EBT Margin (2013 - 2026) Analysis & Trends

Harrow's EBT Margin history runs 14 years deep, the most recent figure standing at 62.39% for Q1 2026.

  • In Q1 2026, EBT Margin fell 2521.0% year-over-year to 62.39%; the TTM figure through Mar 2026 stood at 4.16% (up 596.0% YoY), while the FY2025 annual figure was 0.5%, up 817.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 62.39%, down from 11.67% in the prior quarter.
  • The five-year high for EBT Margin was 11.67% in Q4 2025, with the low at 62.39% in Q1 2026.
  • The 5-year median for EBT Margin is 11.89% (2024), against an average of 15.51%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin surged 4128 bps in 2022, then slumped 3182 bps in 2023.
  • Harrow's EBT Margin stood at 5.19% in 2022, then sank by 613 bps to 26.63% in 2023, then jumped by 135 bps to 9.37% in 2024, then advanced by 25 bps to 11.67% in 2025, then tumbled by 635 bps to 62.39% in 2026.
  • Business Quant data shows HROW's EBT Margin at 62.39% in Q1 2026, 11.67% in Q4 2025, and 1.42% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -10.99%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 47.58%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Harrow 1.55 Bn 1.46 Bn 50.36 Mn -24.44%

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.44%
Mar 31, 2026 -62.39%
Dec 31, 2025 11.67%
Sep 30, 2025 1.42%
Jun 30, 2025 7.84%
Mar 31, 2025 -37.17%
Dec 31, 2024 9.37%
Sep 30, 2024 -8.53%
Jun 30, 2024 -11.89%
Mar 31, 2024 -39.22%
Dec 31, 2023 -26.63%
Sep 30, 2023 -8.32%
Jun 30, 2023 -12.68%
Mar 31, 2023 -26.55%
Dec 31, 2022 5.19%
Sep 30, 2022 -28.17%
Jun 30, 2022 -26.58%
Mar 31, 2022 -11.02%
Dec 31, 2021 -36.09%
Sep 30, 2021 -44.51%